rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1993-9-23
|
pubmed:abstractText |
Heparin inhibits vascular smooth muscle cell proliferation in tissue culture and limits neointimal hyperplasia after experimental arterial injury but has been ineffective in reducing clinical restenosis. We examined how this discrepancy might reflect suboptimal drug-tissue interactions and/or differences in the vascular response to injury.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1215-21
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8353883-Administration, Topical,
pubmed-meshheading:8353883-Angioplasty, Balloon,
pubmed-meshheading:8353883-Animals,
pubmed-meshheading:8353883-Constriction, Pathologic,
pubmed-meshheading:8353883-Female,
pubmed-meshheading:8353883-Heparin,
pubmed-meshheading:8353883-Hyperplasia,
pubmed-meshheading:8353883-Iliac Artery,
pubmed-meshheading:8353883-Infusions, Intravenous,
pubmed-meshheading:8353883-Male,
pubmed-meshheading:8353883-Rabbits,
pubmed-meshheading:8353883-Recurrence,
pubmed-meshheading:8353883-Stents,
pubmed-meshheading:8353883-Thrombosis,
pubmed-meshheading:8353883-Tunica Intima
|
pubmed:year |
1993
|
pubmed:articleTitle |
Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.
|
pubmed:affiliation |
Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|